Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 2

1(25.0%)

4Total

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07111858Not ApplicableRecruiting

Pavlik Harness Treatment vs Monitoring for Treatment of Developmental Dysplasia of the Hip (DDH) in Babies Diagnosed With Graf Type 2 Hips

Role: lead

NCT02955082Phase 2Active Not Recruiting

The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment

Role: collaborator

NCT05395767Not ApplicableRecruiting

LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study

Role: lead

NCT06169163Recruiting

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

Role: collaborator

NCT02482493Not ApplicableActive Not Recruiting

All Polyethylene Versus Metal Backed Tibial Components in Knee Replacement

Role: lead

NCT02298907Completed

CPET in Colorectal Surgery

Role: collaborator

NCT03430024Unknown

Nuclear Myosin VI - a Therapeutic Target in Breast Cancer

Role: lead

NCT01603810Unknown

Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma

Role: lead

All 8 trials loaded